Catalyst Brief

← Calendar

Readoutin 104d

Beijing Suncadia Pharmaceuticals Co., Ltd — SHR-1918/ SHR-1918 placebo

Phase 3 primary completion: A Study of SHR-1918 In Participants With Hypertriglyceridemia.

Date
Mar 2027
Type
Readout
Indication
Hypertriglyceridemia

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.